We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Emergent Biosolutions has entered into an agreement to manufacture Humanigen’s lenzilumab, a potential treatment for COVID-19, ahead of an emergency use filing expected early this year. Read More
Civica Rx, a two-year-old nonprofit organization founded by hospitals and philanthropic groups to address generic drug shortages in the U.S., announced it will build its first manufacturing facility. Read More
Merus will spearhead the early development of oncology drugs, using its proprietary drug platform, while Eli Lilly’s Loxo Oncology subsidiary will provide additional research and marketing. Read More
Lawmakers who want to tackle sky-high drug prices are going to have lots of new ammunition, thanks to the new hospital drug pricing transparency rule from the Centers for Medicare and Medicaid Services (CMS) and the analyses that are now starting to appear because of it. Read More
Pfizer and BioNTech have struck a supply deal with the World Health Organization (WHO)-backed COVAX program, pledging to ship up to 40 million doses of their COVID-19 vaccine this year for an undisclosed price. Read More
Eli Lilly has agreed to pay Dutch drugmaker Merus up to $1.6 billion to develop novel T-cell re-directing bispecific antibodies for treating various cancers. Read More
A new survey has found that interactions between U.S. family medicine residencies and the pharma industry in 2019 continued a decade-long downward trend. Read More
Mylan and three pharmacy benefit managers — CVS Caremark, Express Scripts and OptumRx — must face a class-action lawsuit claiming that the drugmaker paid bribes and kickbacks to the three companies to ensure a monopoly market for EpiPen, a federal judge has ruled. Read More
What would have been the biggest patent verdict in history will not be reinstated in favor of Merck, after the Supreme Court Tuesday declined to hear the pharma giant’s last appeal. Read More
The European Union (EU) and Canada will see temporary reductions in shipments of the Pfizer/BioNTech COVID-19 vaccine as Pfizer upgrades its Belgian facility to meet a goal of producing 2 billion doses annually, raising concerns as global coronavirus cases surge. Read More
Most of the 53 novel drugs approved by the FDA in 2020 were reviewed through at least one expedited approval process, the agency said in a report on the year. Read More